A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma
Preprint in bioRxiv (December 2023)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Preprint in bioRxiv (December 2023)
Article in Anatolian Journal of Medicine (August 2023)
Article in Frontiers in Medicine (February 2023)